lunes, 18 de noviembre de 2019

Microbiome drug development: a rapidly evolving field - STAT

Microbiome drug development: a rapidly evolving field - STAT

First Opinion

STAT Plus: Microbiome drug development: a rapidly evolving field

By PETER BAK


ADOBE
Microbiome-based biopharma companies have more than 200 preclinical and clinical programs underway to treat a wide range of diseases.

No hay comentarios: